Omeros Corporation is a Seattle-based biopharmaceutical company specializing in the development of innovative therapies for various medical conditions. With a strong focus on scientific research and discovery technologies, Omeros is committed to advancing medical knowledge and improving patient outcomes.
The company's pipeline includes a range of promising drug candidates, such as Narsoplimab, OMS721, and CAR T cell therapies, targeting conditions like immune disorders and cancer. Omeros' dedication to patients and its cutting-edge approach to medical advancements make it a key player in the biopharmaceutical industry.
Generated from the website